GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fuse Medical FZMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.03

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$9.0m

FY2016FY2025

Net income

$136,912

FY2016FY2025

Free cash flow

$137,310

FY2016FY2025

Shareholders' equity

$6.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$9.0m$10.7m$16.1m$18.6m$20.4m$21.4m$22.9m$26.3m$26.4m$25.7m
Gross profit$6.5m$6.9m$10.7m$11.5m$11.9m$12.7m$11.1m$13.0m$11.8m$14.4m
Operating income$383,783$721,412$383,820−$815,000−$2.2m−$1.0m−$3.4m−$2.0m$858,857$3.2m
Net income$136,912$513,960$1.5m$3.1m−$1.6m−$1.4m−$3.3m$4.0m$699,678$3.0m
Diluted earnings per share0.000.010.020.04-0.02-0.02-0.050.070.010.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$12.9m$14.5m$16.3m$19.8m$18.3m$17.4m$18.4m$22.2m$19.2m$767,147
Cash and short-term investments$339,721$201,003$238,167$147,854$553,190$1.2m$1.1m$844,314$804,715$667,475
Total liabilities$6.1m$7.9m$15.1m$20.1m$21.7m$19.5m$19.6m$20.7m$27.2m$316,532
Debt$2.6m$2.2m$2.0m$2.3m$2.8m$1.8m$1.9m$1.6m$3.6m$150,000
Shareholders' equity$6.7m$6.6m$1.1m−$310,854−$3.4m−$2.1m−$1.2m$1.5m−$8.0m$450,615
Shares outstanding78m78m70m74m70m75m70m54m66m7m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$172,726−$148,422$443,786$34,799−$1.8m$236,654−$4,739$2.5m$1.6m−$237,906
Capital spending−$35,416−$70,828−$443,786——−$20,757−$15,318−$41,838−$20,334−$20,334
Free cash flow$137,310−$219,250—$34,799−$1.8m$215,897−$20,057$2.4m$1.6m−$258,240
Dividends paid———————−$1.9m−$1.9m−$2.4m

Latest quarters

By quarter end

Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021
Revenue$5.0m$4.0m$4.9m$4.5m$4.7m$4.6m$6.1m$4.3m
Gross profit$3.5m$2.8m$2.6m$3.1m$2.9m$2.9m$3.5m$2.4m
Operating income$368,859−$166,000−$487,879$44,894−$51,621−$439,000−$659,000−$681,000
Net income$307,588−$228,000$3.6m−$9,376−$93,319−$358,000−$352,000−$697,000
Diluted earnings per share0.00-0.000.05-0.00-0.00-0.00-0.01-0.01
Cash from operations——————−$2.0m—
Total assets$19.3m$18.4m$19.8m$19.2m$19.1m$17.8m$18.3m$18.0m
Cash and short-term investments$253,378$210,996—$505,989$603,996$522,487$553,190$1.8m
Debt$2.2m$2.1m$200,000$2.4m$2.6m$2.3m$2.8m$1.8m
Shareholders' equity−$231,627−$539,215−$310,854−$3.9m−$3.9m−$3.8m−$3.4m−$3.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-21.5%-15.9%18.3%
Net income-64.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin67.6%65.4%62.6%56.0%
Operating margin5.6%1.2%-2.6%-2.4%
Net margin3.3%9.6%2.3%2.9%

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings3.40.1
Price to sales0.1—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1733%2997%600%332%1532%3233%194%-47%1983%-29%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 22 Oct 2010.

FY2010
Paid in the year7.31
  • 14.62-to-1 reverse split · 30 May 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.